Massive mature cystic teratoma of the head and neck, masquerading as a glial choristoma, causing respiratory compromise of a neonate

  1. Tessa Kirsty Suttle 1 and
  2. Timothy Els 2
  1. 1 Otorhinolaryngology, Livingstone Tertiary Hospital Complex, Port Elizabeth, South Africa
  2. 2 Head of Clinical Unit, Otorhinolaryngology, Livingstone Tertiary Hospital Complex, Port Elizabeth, South Africa
  1. Correspondence to Dr Timothy Els; Drtimels@hotmail.com

Publication history

Accepted:12 Apr 2023
First published:27 Apr 2023
Online issue publication:27 Apr 2023

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Glial choristoma of the head and neck is a rare, benign congenital malformation consisting of a mass of heterotopic glial cells. In cases involving the upper aerodigestive tract, this can present with upper airway obstruction. In the acute setting, this can lead to diagnostic challenges due to the broad differential, as well as the additional difficulties in obtaining appropriate imaging and tissue samples due to the potential risk of airway compromise. We present a case of a neonate born with a large heterogenous mass involving the upper aerodigestive tract and multiple deep neck spaces which resulted in upper airway compromise requiring emergency surgical intervention in the form of a paediatric tracheostomy. We will discuss the histological findings which initially suggested a glial choristoma, work-up and treatment of this patient with the aim of supplementing the limited existing clinical knowledge of this congenital anomaly and understanding the implications of a paediatric tracheostomy in our setting.

Background

Congenital masses of the deep neck spaces and oral cavity are rare and usually benign in nature but may potentially cause life threatening upper airway obstruction.1 2 The broad differential for masses in this region includes cysts, pseudocysts (including ranulas), neoplasms, inflammatory conditions and infections.1–3 Making an accurate diagnosis can be challenging due to the broad differential, as well as the potential risk of airway compromise. This is particularly problematic for both imaging (where a child may require sedation) and histological diagnosis (where sedation, anaesthesia and potential bleeding are all risks for airway compromise).

A choristoma is a congenital heterotopic mass of microscopically normal cells, occurring in an abnormal location.1 These occur mainly in the head and neck region,4 and may contain heterotopic gastric mucosa, neural tissue, cartilage, bone or epithelium.1 Glial choristoma refers to ectopic central nervous tissue, embryologically linked to an encephalocele, although it is not continuous with the brain.5 According to the literature, the most commonly occurring glial choristoma is a nasal glioma, with the parapharyngeal space and oral cavity being extremely rarely involved.4 6 Within the oral cavity and parapharyngeal space, lesions most frequently affect the palatopharyngeal area, followed by the tongue, oropharynx, upper lip and submandibular area.4–7

A teratoma involving the oropharynx is a rare benign congenital growth comprising cells from all three germ layers.8 9 Overall incidence is 1 in 4000 live births, with only 2% involving the oral cavity and oropharynx (1 in 35 000–200 000 000 live births).9 These may be associated with other congenital malformations in up to 6% cases, with cleft palate most commonly seen.9 In this case report, we present a neonate born with a large parapharyngeal and oral cavity mass, diagnosed on three histological samples as a glial choristoma which resulted in upper airway compromise requiring surgical intervention. We will discuss the histological findings, work-up and treatment of this patient with the aim of supplementing the limited existing clinical knowledge of this congenital anomaly and understanding the implications of a paediatric tracheostomy in our setting.

Case presentation

A female neonate was born via normal vertex delivery to a mother in her 20s in the Eastern Cape Province, South Africa. During this pregnancy, the mother was diagnosed with HIV and was initiated on appropriate treatment 16 weeks prior to delivery. On delivery, the child was noted to have a large 4×6.5 cm mass involving the entire left side of the face, oral cavity and oropharynx. This mass was not identified during antenatal sonography. APGAR scores (Appearance, Pulse, Grimace, Activity and Respiration) were 8 and 10 with no initial evidence of upper airway compromise, but the neonate was referred to a tertiary paediatric hospital in the Eastern Cape, where they were monitored closely in a high care setting as the mass appeared to be enlarging and would require definitive management. The child had no other congenital malformations of the major organ systems and no clear evidence of a clinically identifiable genetic syndrome. Initially, the patient was comfortable in room air and did not require supplemental oxygen or support; however, on the third day of life they developed acute upper airway obstruction and required an immediate emergency tracheostomy.

Investigations

An ultrasound of the mass showed a heterogenous lesion with numerous cystic and solid components. A fine-needle aspirate was taken and sent for cytology, although this was unfortunately not diagnostic, and a formal biopsy was required. A tissue biopsy from the oral portion of the mass showed an unencapsulated lesion in the subepithelial stroma comprising neuroglial tissue including glial tissue, meningothelium and choroid plexus. Intervening fibrosis and hyalinised blood vessels were present and there was an overlying granulation tissue response, however there was no evidence of malignancy. Immunochemical staining was positive for glial fibrillary acid protein (GFAP) and S-100 protein.

A contrast-enhanced MRI showed a large lesion within the left infratemporal fossa, parapharyngeal, retropharyngeal and buccal spaces, with extension into the left maxillary alveolar process, palatine bone and soft palate. T1 weighted imaging showed a soft tissue mass which was isointense to normal intracranial tissue, with cystic regions of breakdown within the mass. It was contrast-enhancing on the post-contrast sequences and there was no direct intracranial communication as confirmed with the T2 weighted sequences (figures 1–5).

Figure 1

T1W coronal sequence showing isointense mass involving buccal region, maxilla, infratemporal fossa. T1W, T1 weighted.

Figure 2

T1W post-contrast coronal sequence showing areas of enhancement within mass, as well as cystic and solid areas. T1W, T1 weighted.

Figure 3

T2W axial sequence showing heterogenous mass. T2W, T2 weighted.

Figure 4

T2W coronal sequence showing absence of connection between brain and mass. T2W, T2 weighted.

Figure 5

T2W coronal sequence showing heterogenous mass within left infratemporal fossa, alveolar ridge, palate, buccal region. T2W, T2 weighted.

Differential diagnosis

Our primary diagnosis at this point was a glial choristoma, as histological examinations of multiple biopsies were reported as such. However, due to the heterogeneity of the mass on MRI there was also concern that the congenital growth may be a mature teratoma.

Treatment

Due to the extent of the mass, it was decided that it would be more appropriate to refer the patient for definitive surgical excision and reconstruction at a dedicated tertiary paediatric otorhinolaryngology unit, with appropriate interdisciplinary input. The neonate was subsequently referred to a tertiary children’s hospital in the Western Cape for further management. The patient received respiratory support and tracheostomy care in a neonatal intensive care unit prior to transfer.

Once in this referral unit, two additional biopsies confirmed mature neuroglial tissue. Histology of the whole tumour post resection, however, revealed neuroglial, skin and mesenchymal soft tissue elements. A final diagnosis of a mature cystic teratoma was made.

Outcome and follow-up

The surgical excision and reconstruction were successful, and the patient is currently receiving ongoing follow-up and rehabilitation from a multidisciplinary team in the Western Cape.

Discussion

The terms ‘choristoma’ or ‘heterotopia’ most accurately describe the congenital malformation of microscopically normal tissue occurring in an abnormal location.6 A glial choristoma is not neoplastic in nature as it grows alongside the surrounding tissue in an expansive manner without infiltrating it.6 These occur mainly in the head and neck region,4 and contain heterotopic neural tissue.1 Glial choristoma refers to ectopic central nervous tissue which is not continuous with the brain.5 This should be differentiated from a hamartoma, which refers to a tumour consisting of an overgrowth of mature normal cells occurring where these cells are usually located.10

Glial choristomas are rare congenital malformations found primarily in neonates and young children. Approximately 250 cases affecting the nasal area and 33 cases affecting the oral cavity have been described in the literature.3 4 No previous cases have been described in the Eastern Cape, South Africa. Within the oral cavity, the tongue is most commonly involved, followed by the palatopharyngeal complex.3–7 11 12 Few cases have been described which involve the infratemporal fossa. Of note, a high percentage (estimated 35%) of oropharyngeal glial choristomas are associated with cleft palate.6

Two major theories regarding the pathogenesis of glial choristoma have been described. The first suggests that nasal and palatopharyngeal glial choristomas develop as a result of herniation of neural glial tissue from the developing brain due to failed embryonic development of the bony cranium.3 5 6 10 The presence of a fibrous stalk connecting some nasal choristomas with intracranial contents supports this theory.6 The second theory suggests that glial choristomas of the tongue develop from abnormal migration of pluripotent cells from the developing neural tube, which become integrated with the myogenic precursors from the occipital somites which migrate to the developing tongue to give rise to lingual muscle.3 5 6 10

Of note, there is no documented relationship between HIV infection and congenital choristoma. HIV is known to be associated with an increased risk of developing certain cancers such as Kaposi sarcoma, non-Hodgkin’s lymphoma, oral cancers and cervical cancer which is thought to be due to altered immune modulation.13 The possibility of association between congenital choristoma occurrence and HIV exposure is an area in which research is currently lacking.

Diagnosis of glial heterotopia can be supported with imaging such as ultrasound, CT and MRI.2 6 14 MRI is superior in evaluating soft tissue involvement within the oral cavity and oropharynx, although both CT and MRI are used in assessing the extent of the lesion, as well as its vascularity when contrast enhancement is used.2 6 In our case, the ultrasound was not of particular diagnostic value; however, the MRI detailed the soft tissue involvement of the mass, its rich vascular supply and confirmed that there was no intracranial continuity. Definitive diagnosis requires histopathological examination. Microscopic examination confirms mature glial tissue (primarily astrocytes) within a fibrovascular stroma.2 3 6 11 Less frequently, there may be oligodendrocytes, choroid plexus, neurons and meningeal components seen, as in our case.2 6 These lesions are immunocytochemically reactive to GFAP and S-100 protein.2 3 6 11 There have also been cases described with reactions to anti-neuron-specific enolase antibodies and neurofilament stains.2 6 11

A mature cystic teratoma is a rare benign congenital growth comprising cells from all three germ layers.8 9 Within the oral cavity and oropharynx the incidence is 1 in 35 000–200 000 000 live births.9 When protruding from the oral cavity or face, they should be identifiable during antenatal sonography as early as 15–16 weeks of gestation.9 15 There are cases described where diagnosis using antenatal ultrasound is only made in the third trimester which may be due to progressive growth in mass size during gestation.15 In cases associated with polyhydramnios, there should be a high suspicion for airway compromise and appropriate planning for airway management immediately after delivery should be made.9 In this case the growth was unfortunately not identified during the antenatal period. This may have been due to the mass being too small to identify at the time of antenatal ultrasound.

MRI findings for a teratoma are non-specific, and definitive diagnosis is made on histology.8 As a biopsy is only a representative of part of a mass, it is possible that tissue from only one germ cell layer is identified during biopsy, as was seen in this case, and an incorrect diagnosis is made without complete surgical resection. This highlights the importance of sending full tumour resections for histology even when a biopsy diagnosis exists prior to surgery.

As both glial choristomas and mature cystic teratomas are benign conditions, the treatment of choice is complete surgical excision, which is curative.2 3 6 Recurrence may occur if excision is incomplete.2 3 However, the site or extent of these lesions is not always amenable to single stage excision and may require a staged-resection approach with input from numerous surgical disciplines.14 Palatoplasty and maxillofacial reconstruction may be needed post surgical excision of glial heterotopia occurring in the oral cavity and parapharyngeal region, as is the case with our patient.

When occurring in the upper aerodigestive tract, oral cavity or deep neck spaces, these growths have the potential risk for upper airway compromise requiring surgical intervention. This is of importance in the paediatric population where tracheostomy insertion is more technically challenging and associated with higher morbidity and mortality rates.16 17 Residing far from the hospital is a known risk factor for increased mortality from a paediatric tracheostomy, which is of significant concern in our setting. The majority of tracheostomy-associated morbidity and mortality results from granuloma, infection, cannula obstruction and accidental decannulation.16 17 Because of this, definitive treatment of both glial choristoma and teratoma is needed to reduce the morbidity and mortality associated with paediatric tracheostomy. In our case, for example, the neonate requires in-patient tracheostomy care with regular suctioning and respiratory support which the family is unable to provide at home due to financial constraints, electricity supply concerns and distance to appropriate medical care.

Learning points

  • While extremely rare, both glial choristoma and mature cystic teratoma of the upper aerodigestive tract may result in acute upper airway obstruction requiring a surgical airway.

  • These conditions are poorly understood, and management requires a multidisciplinary approach for favourable outcomes.

  • Antenatal sonography is an important tool to diagnose congenital masses of the upper aerodigestive tract to plan for appropriate airway management and resection after birth.

  • Paediatric tracheostomy care, both inpatient and outpatient, continues to pose serious challenges to the South African healthcare environment.

  • This case highlights the need for disciplines involved in the care of neonates to have a well-structured approach to any form of congenital upper airway obstruction.

Ethics statements

Patient consent for publication

Footnotes

  • Contributors TS contributed to conception and design of report, data acquisition, drafting and writing article, and editing the manuscript. TE contributed to consultant level management of case, analysis of data and critical revision.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer